Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment

Crimean-Congo hemorrhagic fever (CCHF) virus has the widest geographic range of all tick-borne viruses and is endemic in more than 30 countries in Eurasia and Africa. Over the past decade, new foci have emerged or re-emerged in the Balkans and neighboring areas. Here we discuss the factors influenci...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltezou, Helena C, Papa, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256116/
https://www.ncbi.nlm.nih.gov/pubmed/22152109
http://dx.doi.org/10.1186/1741-7015-9-131
_version_ 1782221035243831296
author Maltezou, Helena C
Papa, Anna
author_facet Maltezou, Helena C
Papa, Anna
author_sort Maltezou, Helena C
collection PubMed
description Crimean-Congo hemorrhagic fever (CCHF) virus has the widest geographic range of all tick-borne viruses and is endemic in more than 30 countries in Eurasia and Africa. Over the past decade, new foci have emerged or re-emerged in the Balkans and neighboring areas. Here we discuss the factors influencing CCHF incidence and focus on the main issue of the use of ribavirin for treating this infection. Given the dynamics of CCHF emergence in the past decade, development of new anti-viral drugs and a vaccine is urgently needed to treat and prevent this acute, life-threatening disease.
format Online
Article
Text
id pubmed-3256116
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32561162012-01-12 Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment Maltezou, Helena C Papa, Anna BMC Med Commentary Crimean-Congo hemorrhagic fever (CCHF) virus has the widest geographic range of all tick-borne viruses and is endemic in more than 30 countries in Eurasia and Africa. Over the past decade, new foci have emerged or re-emerged in the Balkans and neighboring areas. Here we discuss the factors influencing CCHF incidence and focus on the main issue of the use of ribavirin for treating this infection. Given the dynamics of CCHF emergence in the past decade, development of new anti-viral drugs and a vaccine is urgently needed to treat and prevent this acute, life-threatening disease. BioMed Central 2011-12-08 /pmc/articles/PMC3256116/ /pubmed/22152109 http://dx.doi.org/10.1186/1741-7015-9-131 Text en Copyright ©2011 Maltezou and Papa; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Maltezou, Helena C
Papa, Anna
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
title Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
title_full Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
title_fullStr Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
title_full_unstemmed Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
title_short Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
title_sort crimean-congo hemorrhagic fever: epidemiological trends and controversies in treatment
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256116/
https://www.ncbi.nlm.nih.gov/pubmed/22152109
http://dx.doi.org/10.1186/1741-7015-9-131
work_keys_str_mv AT maltezouhelenac crimeancongohemorrhagicfeverepidemiologicaltrendsandcontroversiesintreatment
AT papaanna crimeancongohemorrhagicfeverepidemiologicaltrendsandcontroversiesintreatment

Ejemplares similares